KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer
Authors
Keywords
Kras, Colorectal cancer, Prognosis
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 33, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-12-10
DOI
10.1186/s13046-014-0104-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
- (2014) Alain R Thierry et al. NATURE MEDICINE
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Tracking the Molecular Features of Nonpolypoid Colorectal Neoplasms: A Systematic Review and Meta-Analysis
- (2013) Quirinus J M Voorham et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer
- (2013) D. Tougeron et al. ANNALS OF ONCOLOGY
- The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
- (2013) V Eklöf et al. BRITISH JOURNAL OF CANCER
- Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
- (2013) Hye-Ryoun Kim et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
- (2012) Tomoya Yokota Anti-Cancer Agents in Medicinal Chemistry
- Modified PNA-PCR method
- (2012) Shaorong Yu et al. CANCER BIOLOGY & THERAPY
- BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics
- (2012) A. I. Phipps et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Is K-ras Gene Mutation a Prognostic Factor for Colorectal Cancer
- (2012) JiaoJiao Ren et al. DISEASES OF THE COLON & RECTUM
- A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas
- (2012) Sylwia Jancik et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
- (2011) T Yokota et al. BRITISH JOURNAL OF CANCER
- A fast, cost-efficient and sensitive approach for KRAS mutation detection using multiplexed primer extension with IP/RP-HPLC separation
- (2011) Sascha Tierling et al. INTERNATIONAL JOURNAL OF CANCER
- A comparison of ARMS and direct sequencing for EGFR mutation analysis and Tyrosine Kinase Inhibitors treatment prediction in body fluid samples of Non-Small-Cell Lung Cancer patients
- (2011) Yi Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: Comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue
- (2011) Mi Jung Kwon et al. PATHOLOGY RESEARCH AND PRACTICE
- The frequency of KRAS mutation detection in human colon carcinoma is influenced by the sensitivity of assay methodology: A comparison between direct sequencing and real-time PCR
- (2010) Takashi Kobunai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Oncosuppressor methylation: A possible key role in colon metastatic progression
- (2010) Stefania Tommasi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
- (2010) Alberto Bardelli et al. JOURNAL OF CLINICAL ONCOLOGY
- A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples
- (2010) Gillian Ellison et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Detection of Low-Level KRAS Mutations Using PNA-Mediated Asymmetric PCR Clamping and Melting Curve Analysis with Unlabeled Probes
- (2010) Ji Eun Oh et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Are RAS mutations predictive markers of resistance to standard chemotherapy?
- (2009) Yohann Loriot et al. Nature Reviews Clinical Oncology
- High-Fidelity DNA Polymerase Enhances the Sensitivity of a Peptide Nucleic Acid Clamp PCR Assay for K-ras Mutations
- (2008) Bjørnar Gilje et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
- (2008) Helena Linardou et al. LANCET ONCOLOGY
- High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice
- (2008) D. Santini et al. ONCOLOGIST
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started